Mary Kate Tracey

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

Neil C. Dalvie, Sergio A. Rodriguez‐Aponte, Brittany L. Hartwell et al. · Proceedings of the National Academy of Sciences · 2021 · 101 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +16

Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered <i>Komagataella phaffii</i>

Neil C. Dalvie, Andrew M. Biedermann, Sergio A. Rodriguez‐Aponte et al. · Biotechnology and Bioengineering · 2021 · 35 citations · Full text

Pharmacy, Bioengineering, Biotechnology +17

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens

Nishant Sawant, Kawaljit Kaur, David A. Holland et al. · Journal of Pharmaceutical Sciences · 2020 · 21 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmaceutical Biotechnology +17

Development of a platform process for the production and purification of single‐domain antibodies

Laura E. Crowell, Chaz Goodwine, Carla Solange Sosa Holt et al. · Biotechnology and Bioengineering · 2021 · 20 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

Neil C. Dalvie, Joseph R. Brady, Laura E. Crowell et al. · Microbial Cell Factories · 2021 · 19 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17